ArticleFrontiers in oncology2025
Comparative analysis of multi-zone peritumoral radiomics in breast cancer for predicting NAC response using ABVS-based deep learning models.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive review.NPJ breast cancer · 2026Review
- Article
- A Simple and Robust MRI Radiomics Feature for Predicting Pathological Complete Response: A Proof-of-Concept Study in Breast Cancer Neoadjuvant Chemotherapy.Cancer reports (Hoboken, N.J.) · 2026Article
- Differentiation between G3 pancreatic neuroendocrine tumor and pancreatic neuroendocrine carcinoma based on intratumor and peritumor CT value ratio and abnormal vascular network.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Peritumoral characteristics demonstrate significant predictive value for neoadjuvant chemotherapy (NAC) response in breast cancer (BC) through tumor-stromal interactions. Radiomics analysis of peritumoral regions has shown robust capability in predicting treatment outcomes; however, the optimal peritumoral thickness for maximizing predictive accuracy remains undefined. Objective: To establish a clinically implementable framework for early identification of NAC non-responders through standardized prediction modeling. This study aims to determine the optimal peritumoral thickness for NAC response prediction by training and systematically comparing artificial intelligence (AI)-driven radiomics models across multiple peritumoral zones using Automated Breast Volume Scanning (ABVS). Methods: A total of 402 BC patients who received NAC were retrospectively analyzed. Pre-treatment ABVS images were processed to extract radiomic features from five regions of interest (ROIs): the intratumoral region (R0) and four consecutive peritumoral zones (R2-R8) extending outward at 2-mm intervals. The study cohort was divided into training and testing cohorts. ROI-specific TabNet models were developed using the training cohort data. Comparative analysis was performed in the testing cohort through comprehensive performance evaluation, including discrimination, calibration, clinical utility assessment, and classification metrics, to identify the optimal peritumoral zone. The radiomics features of the best-performing model were ranked by importance, with subsequent ablation studies validating the predictive contribution of high-ranking features. Results: Among the study population, 138 patients (34.3%) were classified as NAC non-responders. Model evaluation demonstrated progressively improved predictive performance from R0 to R6, with area under the ROC curves increasing from 0.681 to 0.845. The R6 model demonstrated optimal performance with accuracy of 0.810 and precision of 0.765. The combined model integrating R0 and R6 features enhanced predictive capability, achieving accuracy of 0.909, precision of 0.841, and recall of 0.902. Feature importance analysis identified textural heterogeneity and volumetric characteristics as the most influential variables, with the top features derived predominantly from the 6-mm peritumoral region. Conclusion: The 6-mm peritumoral zone demonstrated optimal predictive value for NAC response, with the AI-driven combined intratumoral-peritumoral model achieving superior performance. This standardized ABVS-based radiomics approach enables early identification of potential NAC non-responders, facilitating timely therapeutic modifications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.